Biosimilars Market by Application and Geography | Global Forecast to
Biosimilar report by Technavio highlights major market trends, biosimilar market potential, top revenue-generating segments, and other factors impacting the market size.
NEW YORK, Sept. 22, 2021 /PRNewswire/ — The biosimilars market is poised to grow by USD 31.40 billion during 2021-2025, progressing at a CAGR of 25% during the forecast period, according to Technavio. The report offers an up-to-date analysis of the growth variance and the Y-O-Y growth rate.
Identify sustainable growth opportunities and make informed business decisions.
Download our Free Sample Report
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Merck and Co. Inc., Novartis AG, Pfizer Inc., and Viatris Inc. are some of the major market participants. Although the price advantage of biosimilars over biologics will offer immense growth opportunities, market access barriers for biosimilars will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Biosimilars Market 2021-2025: Segmentation
Biosimilars Market is segmented as below:
Gain insights on the competitive landscape and the growth contribution of each segment. Download the free sample here:
https://www.technavio.com/talk-to-us?report=IRTNTR70710
Related Reports on Health Care Include:
Global Biosimilar Monoclonal Antibodies (mAbs) Market – Global biosimilar monoclonal antibodies (mAbs) is segmented by application (cancer and non-cancer) and geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report
Global Monoclonal Antibodies Market – Global monoclonal antibodies market is segmented by application (oncology, autoimmune disorders, infectious diseases, and other applications) and geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report
Biosimilars Market 2021-2025: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our biosimilars market report covers the following areas:
This study identifies government initiatives to increase the use of biosimilar medicines as one of the prime reasons driving the biosimilars market growth during the next few years.
Biosimilars Market 2021-2025: Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the Biosimilars Market. Backed with competitive intelligence and benchmarking, our research report on the Biosimilars Market is designed to…
Read More: Biosimilars Market by Application and Geography | Global Forecast to